Literature DB >> 33429260

The cross-talk between signaling pathways, noncoding RNAs and DNA damage response: Emerging players in cancer progression.

Faezeh Malakoti1, Forough Alemi2, Simin Younesi3, Maryam Majidinia4, Bahman Yousefi2, Pejman Morovat5, Nafiseh Khelghati2, Masoomeh Maleki2, Ansar Karimian6, Zatollah Asemi7.   

Abstract

The DNA damage response (DDR) pathway's primary purpose is to maintain the genome structure's integrity and stability. A great deal of effort has done to understand the exact molecular mechanisms of non-coding RNAs, such as lncRNA, miRNAs, and circRNAs, in distinct cellular and genomic processes and cancer progression. In this regard, the ncRNAs possible regulatory role in DDR via modulation of key components expression and controlling repair signaling pathway activation is validated. Therefore, in this article, we will discuss the latest developments of ncRNAs contribution in different aspects of DNA repair through regulation of ATM-ATR, P53, and other regulatory signaling pathways.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATM; ATR; DNA damage; DNA repair; Noncoding RNA

Year:  2021        PMID: 33429260     DOI: 10.1016/j.dnarep.2020.103036

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  2 in total

Review 1.  DNA repair and damage pathways in mesothelioma development and therapy.

Authors:  Faezeh Malakoti; Niloufar Targhazeh; Erfan Abadifard; Reza Zarezadeh; Sahar Samemaleki; Zatollah Asemi; Simin Younesi; Reza Mohammadnejad; Seyed Hadi Hossini; Ansar Karimian; Forough Alemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-05-02       Impact factor: 6.429

2.  Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.

Authors:  Kaniz Fatema; Zachary Larson; Jared Barrott
Journal:  Biocell       Date:  2022-06-13       Impact factor: 1.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.